-
Can the informed consent process actually provide too much information? That's the contention of HIV researcher Susan Allen, MD, MPH, who points to a recent study she tried to conduct in Zambia of participants' knowledge about contraceptive options.
-
The Food and Drug Administration is proposing to amend its regulations to expand the scope of clinical investigator disqualification.
-
In a large, randomized, controlled trial, screening for prostate cancer did not have a significant effect on mortality from prostate cancer after 20 years of follow-up.
-
The use of low-dose aspirin is associated with an almost two-fold increase in the risk of upper gastrointestinal bleeding compared with nonuse and this risk is further increased when low-dose aspirin is combined with clopidogrel, oral anticoagulants, nonsteroidal anti-inflammatory drugs, or high-dose oral corticosteroids.
-
A tyrosine kinase inhibitor has been approved for the treatment of medullary thyroid cancer (MTC).
-
-
Anticholinergic drugs for COPD; pioglitazone for diabetes prevention; insulin degludec in Phase 3 trials; and FDA Actions.
-
Plasma concentrations of 25-hydroxyvita-min D [25(OH)D] decrease after an inflammatory insult such as knee surgery and, therefore, are unlikely to be a reliable measure of 25(OH)D status in patients with evidence of a significant inflammatory response.
-
-
